000 | 00985 a2200277 4500 | ||
---|---|---|---|
005 | 20250515234408.0 | ||
264 | 0 | _c20111102 | |
008 | 201111s 0 0 eng d | ||
022 | _a1179-6901 | ||
024 | 7 |
_a10.2165/11539310-000000000-00000 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVelpandian, Thirumurthy | |
245 | 0 | 0 |
_aClosed gateways--can neuroprotectants shield the retina in glaucoma? _h[electronic resource] |
260 |
_bDrugs in R&D _c2010 |
||
300 |
_a93-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Comment | ||
650 | 0 | 4 |
_aErigeron _xchemistry |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlaucoma, Open-Angle _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPlant Extracts _xpharmacology |
650 | 0 | 4 |
_aVisual Fields _xdrug effects |
773 | 0 |
_tDrugs in R&D _gvol. 10 _gno. 2 _gp. 93-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2165/11539310-000000000-00000 _zAvailable from publisher's website |
999 |
_c20036782 _d20036782 |